Aptamer Group PLC (AIM:APTA)
London · Delayed Price · Currency is GBP · Price in GBX 0.5500
-0.0250 (-4.35%)
May 26, 2026, 4:24 PM GMT
Aptamer Group Market Cap
Aptamer Group has a market cap or net worth of 19.87 million as of May 26, 2026. Its market cap has increased by 169.64% in one year.
Market Cap
19.87M
Enterprise Value
18.67M
Revenue
1.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.55
Market Cap Chart
Since December 22, 2021, Aptamer Group's market cap has decreased from 97.55M to 19.87M, a decrease of -79.63%. That is a compound annual growth rate of -30.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 19.87M | -31.48% |
| Dec 31, 2025 | 28.99M | 308.04% |
| Dec 31, 2024 | 7.11M | 32.20% |
| Dec 29, 2023 | 5.37M | -84.73% |
| Dec 30, 2022 | 35.20M | -62.04% |
| Dec 31, 2021 | 92.73M | -4.95% |
| Dec 22, 2021 | 97.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hemogenyx Pharmaceuticals | 46.92M |
| Poolbeg Pharma | 35.54M |
| Sareum Holdings | 28.41M |
| ImmuPharma | 26.83M |
| SkinBioTherapeutics | 25.14M |
| Arecor Therapeutics | 24.92M |
| Palatin Technologies | 19.12M |
| IXICO | 18.86M |